Efficacy and Safety of Different Norepinephrine Regimens for Prevention of Spinal Hypotension in Cesarean Section: A Randomized Trial

Table 3

Hypotension and hypertension.

	Control	NE 1	NE 2	NE 3	value
Hypotension
Before delivery	20 (66.7%, 48.8%–84.6%)	(31.0%, 13.1%–48.9%)	(16.7%, 2.5%–30.8%)	(17.9%, 2.7%–33%)	<0.001
After delivery	6 (20%, 4.8%–35.2%)	2 (6.9%, 0%–16.7%)	1 (3.3%, 0%–10.2%)	2 (7.1%, 0%–17.3%)	0.131
Total	26 (86.7%, 73.8%–99.6%)	(37.9%, 19.1%–56.7%)	(20.0%, 4.8%–35.2%)	(25.0%, 7.9%–42.1%)	<0.001
Hypertension
Before delivery	1 (3.3%, −3.5%–10.2%)	8 (27.5%, 10.3%–44.9%)	(16.7%, 2.5%–30.8%)	(57.1%, 37.6%–76.7%)	<0.001
After delivery	2 (6.7%, 2.8%–16.1%)	4 (13.8%, 0.4%–27.1%)	6 (20%, 4.8%–35.2%)	5 (17.9%, 2.7%–33%)	0.479
Total	3 (10%, −1.4%–21.4%)	(41.4%, 22.3%–60.4%)	(36.6%, 18.4%–55%)	(75%, 57.9%–92.1)	<0.001

Data were presented as number (percentage, 95% confidence interval). compared with control; compared with control; compared with NE 3; compared with NE 3.